Latest News & Updates

Breaking News

  • 11 hours ago

  • Vaibhavi M.

Alvotech And Sandoz Partner To Launch Biosimilars In Canada, Australia And New Zealand, New Agreements Expand Alvotech’s Biosimilar Footprint
Breaking News
Sparrow Pharmaceuticals Appoints Industry Leader Carlo Incerti, M.D., To Board Of Directors As Company Prepares Pivotal Trials For Clofutriben In Type 2 Diabetes

Simantini Singh Deo

Other trending news you may like to read

Alvotech And Sandoz Partner To Launch Biosimilars In Canada, Australia And New Zealand, New Agreements Expand Alvotech’s Biosimilar Footprint

Alvotech and Sandoz sign new biosimilar supply and commercialisation deals for Canada, Australia, and New Zealand to expand patient access to affordable biologics.

Vaibhavi M.

Pharma Now

Sparrow Pharmaceuticals Appoints Industry Leader Carlo Incerti, M.D., To Board Of Directors As Company Prepares Pivotal Trials For Clofutriben In Type 2 Diabetes

Sparrow Pharmaceuticals appoints biopharma veteran Carlo Incerti, M.D., to its Board, strengthening leadership ahead of key cardiometabolic trials.

Simantini Singh Deo

Pharma Now

Quotient Therapeutics Names Susan Keefe As New CFO, Bringing 30 Years Of Life Science Finance And Recent Experience As Acting CFO Via Flagship Pioneering

Quotient Therapeutics appoints Susan Keefe as CFO to strengthen somatic genomics–driven drug development and partnerships.

Simantini Singh Deo

Pharma Now

FDA Issues Complete Response Letter For Pharming’s Joenja® sNDA In Children 4–11 With Rare APDS, Citing Pediatric Dose And Batch Testing Data Needs

FDA issues CRL for Joenja in children 4–11 with APDS, requesting additional PK and testing data. Approval for ages 12+ unchanged.

Simantini Singh Deo

Pharma Now